Resynchronization/Defibrillation for Ambulatory Heart Failure Trial in Patients With Permanent Atrial Fibrillation

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It plans to enroll 200 participants.

Also called NCT01994252

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 200 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01994252
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Canada (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01994252. Randomized; quadruple masking; primary purpose treatment. Start 2014-06-04 (actual); primary completion 2024-01-31 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Resynchronization/Defibrillation for Ambulatory Heart Failure Trial in Patients With Permanent Atrial Fibrillation
Acronym
RAFT-PermAF
Condition
Heart Disease
Condition
Congestive Heart Failure
Intervention (Device)
Optimal Medical therapy plus ICD
Intervention (Device)
Optimal Medical therapy plus CRT/ICD
Lead sponsor
Ottawa Heart Institute Research Corporation (class: other)
Collaborator
Canadian Institutes of Health Research (CIHR) (class: other government)

Record details

Record id
cardio:ct-nct01994252
Content hash
740c0ab4362f2042cf585049b58bb933629ddf11d777eca0094a4621c0ed670e